Sue Goldie is a physician and public health researcher whose
leadership, rigorous analyses, and creative interventions are transforming
women’s healthcare around the world. Incorporating mathematical modeling, the
science of medical decision-making, and risk analysis, she has successfully
identified important new strategies to improve women’s health in underserved
populations. Together with her collaborators, Goldie has developed complex and
comprehensive epidemiological models for
diseases such as HIV, gonorrhea, chlamydia, herpes, and hepatitis C. By
weighing disease characteristics and quantitatively assessing possible health
interventions for potential populations, Goldie has translated her models into
actionable information to guide global health interventions and policies. A
focus of Goldie’s research is the human papilloma virus (HPV) and its link to
cervical cancer, the most common cause of cancer death in women worldwide.
Combining clinical, scientific and mathematical methodology, Goldie has demonstrated
that non-physicians can be trained to conduct direct visual inspections or HPV
testing to detect early cervical cancer, a more practical and cost-effective
approach than the expensive and technically challenging Pap smear screening
method. She has taken her findings to the field, creating practical,
sustainable cervical cancer-screening programs in Haiti, India, Kenya, Peru,
South Africa, and Thailand. Indeed, by bridging the gap between clinical
researchers and global policy-makers, Goldie has already enhanced the lives of
tens of thousands of women and has the potential to do so on a broader scale
still.
Sue Goldie received her M.D. (1988) from Albany Medical
College, and completed her residency (1988-91) at Yale University-New Haven
Medical Center. She returned to classes while still seeing patients, and
received her M.P.H. (1997) from Harvard University. She was a fellow at
Harvard’s Center for Risk Analysis (1997-99) and is currently an associate
professor of health policy and decision science in the Department of Health
Policy and Management at the Harvard School of Public Health.